查加斯病:流行病学,诊断和治疗
Michael C Swett1, Danny L Rayes1, Silvia Vidal Campos2
1Department of Internal Medicine, MedStar Georgetown University Hospital, Washington, DC, USA.
Current cardiology reports
|August 8, 2024
概括
查加斯病现在在美国被发现,流行病学正在发展,治疗选择有限. 需要进一步的研究来确定这种寄生虫感染的抗寄生虫使用和治愈标志物.
科学领域:
- 寄生虫学的寄生虫学
- 传染性疾病 传染性疾病
- 流行病学 流行病学
背景情况:
- 由*Trypanosoma cruzi*引起的查加斯病是一个重大的公共卫生问题.
- 对其流行病学的传统理解正受到新数据的挑战.
研究的目的:
- 审查关于查加斯病流行病学的最新文献.
- 概述查加斯病的最新诊断方法.
- 描述当前的抗寄生虫治疗策略及其局限性.
主要方法:
- 关于查加斯病的最新研究的综合文献综述.
- 对流行病学数据,诊断进展和治疗结果的分析.
- 综合有关临床管理和新兴研究的信息.
主要成果:
- 美国越来越多地报告了本土的查加斯病病例,扩展到拉丁美洲以外.
- 寄生虫类型单位显示出更大的地理混合,使传统的区域分类复杂化.
- 建议对具有特定暴露风险的个人进行查,包括前往特有病区的旅行,家族病史和生活条件.
- 目前的抗寄生虫疗法 (二,尼福蒂莫克斯) 在治疗查加斯心肌病症方面具有未明确的作用.
- 讨论了心脏移植的指示和查加斯病的治疗方法.
结论:
- 对抗长期查加斯病的抗寄生虫药物的疗效进行进一步的研究是有必要的.
- 开发用于感染和治愈的新生物标志物对于改善患者管理和治疗验证至关重要.
相关概念视频
Sexually Transmitted Infections
292
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
292
Pulmonary Tuberculosis V
176
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
176
Infection
7.8K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
7.8K
Pulmonary Tuberculosis I
227
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
227
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
Chronic Pancreatitis II: Collaborative Care
79
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
79


